Industry News
Medical Device Industry News
CharmHealth Introduces Multi-Agent AI Copilot Built Directly Into Its EHR
CharmCopilot Moves Beyond Ambient Transcription to Support Triage, Charting, Lab Review, Billing, and Workflow Navigation The post CharmHealth Introduces Multi-Agent AI Copilot Built Directly Into Its EHR first appeared on Medical Device News Magazine.
Verve Medical Treats First Patient in Landmark U.S. Pilot Trial for Uncontrolled Hypertension, Advancing Momentum from Breakthrough TUSK Results
Verve Medical, the leader in non‑invasive renal pelvic denervation (RPD) technology, today announced successful treatment of the first patient in its randomized, double‑blinded U.S. pilot clinical trial for uncontrolled hypertension. This milestone accelerates the company’s
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite
Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows The post Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite first appeared on Medical Device News
CellTolerance®: A Breakthrough in Food Intolerance Diagnosis
The CellTolerance® Test ends years of trial-and-error diets by pinpointing food intolerances through live cellular imaging The post CellTolerance®: A Breakthrough in Food Intolerance Diagnosis first appeared on Medical Device News Magazine.
Baptist Health, Compass Surgical Partners Advance Northeast Florida Surgery Network with Middleburg Surgery Center
Located in southeast Jacksonville near Baptist Medical Center Clay, the multispecialty ASC supports procedures in orthopedics, urology, otolaryngology, pain management, and general surgery. With 15 physician partners committed to the center, the partnership is evaluating
Miniature laser technology could bring lab testing into your home
By studying how various biomolecules interact with each other – for example antibodies in the immune system and xenobiotic antigens – researchers can gain valuable insights leading to new medicines and vaccines or assess whether
First Multi Functional European Training in Augmented SBRT conducted in Monza
The clinic is currently conducting research into single-fraction treatment, where therapy is delivered in one session (while traditional radiotherapy requires 20–40 treatment sessions) The post First Multi Functional European Training in Augmented SBRT conducted in
Centauri Therapeutics granted FDA QIDP status for CTX-187 treatment of Gram-negative bacterial infections
Dr. Debra Barker, Chief Medical Officer, Centauri Therapeutics, said: “This designation from the FDA will be invaluable as we continue to advance toward first in-human trials for CTX-187. The recognition of the potential value of
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain' The post Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care first appeared on Medical Device News Magazine.
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026 The post MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for
Medline Awards Distribution Center of the Year and SAFE Awards
These awards are given to the top-performing Medline distribution centers in the United States across its four tiers of size, as determined by the sales volume distributed out of each facility The post Medline Awards
Stryker launches SmartHospital Platform
"We are dedicated to partnering with our customers on their digital journeys to help elevate care delivery," said Scott Sagehorn, VP/GM of Smart Care at Stryker. "The SmartHospital Platform is designed to evolve alongside health
John P Landino Appointed Chief Development Officer at Healogics
He brings nearly 20 years of experience in business development, marked by a proven ability to forge strategic partnerships with hospital executives and healthcare leaders, supporting rapid and sustainable organizational growth The post John P
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57 The post Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset first appeared on Medical Device News Magazine.
Foundation for Medium Skin Tones | Understanding Your Options
Choosing the right foundation for medium skin tones is really about balancing undertone, depth, and finish so your complexion looks even, natural, and alive rather than flat or over‑corrected. Medium skin sits in a wonderfully
What Makes a Handbag “Right” for a Special Occasion
A handbag plays a quiet but powerful role in shaping how an outfit feels—especially for special occasions. The right one doesn’t just hold your essentials; it completes your look, adds personality, and often becomes the
Avoiding smokers protects your long‑term health
Staying away from smokers matters because secondhand smoke harms the body even in small amounts, and the risks affect nearly every major organ. Medical research shows there is no safe level of exposure, and the
Why Gym Recovery Area Is Becoming Essential in Modern Gyms
A fitness gym that invests in a full recovery and wellness area isn’t just adding amenities — it’s building a complete ecosystem that supports performance, longevity, and member loyalty. A modern gym is no longer
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments
CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day to support faster diagnosis by making
Medicus Pharma reports positive Phase 2 SKNJCT-003 Topline Data observing 73% Clinical Clearance and 40% Histological Clearance at day 57
The company is expected to finalize the Clinical Study Report (CSR) in Q2 2026 to support planned end of Phase 2 (EOP2) meeting with the FDA The post Medicus Pharma reports positive Phase 2 SKNJCT-003